MLH1 and endometrial cancer: The present study suggests that MLH1 methylation status has predictive value in endometrial cancer because whole pelvic radiotherapy and chemotherapy combined with radiotherapy were independently associated with poor disease‐specific survival in MMR‐D nonmethylated but not in MLH1 methylated tumors.